/
Your selections:
Societal preference values for advanced melanoma health states in the United Kingdom and Australia
- Beusterien, K. M., Szabo, S. M., Kotapati, S., Mukherjee, J., Hoos, A., Hersey, P., Middleton, M. R., Levy, A. R.
The needs of patients with advanced, incurable cancer
- Rainbird, K., Perkins, J., Sanson-Fisher, R., Rolfe, I., Anseline, P.
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
- Bernhard, J., Zahrieh, D., Green, M. D., Colleoni, M., Gelber, R. D., Castiglione-Gertsch, M., Price, K. N., Goldhirsch, A., Coates, A. S., Zhang, J. J., Martinelli, G., Basser, R., Hurny, C., Forbes, J. F., Aebi, S., Yeo, W., Thurlimann, B.
Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area
- Isenring, E. A., Capra, S., Bauer, J. D.
Integrin αvβ6-associated ERK2 mediates MMP-9 secretion in colon cancer cells
- Gu, X., Niu, J., Dorahy, D. J., Scott, R. D., Agrez, M. V.
Are you sure you would like to clear your session, including search history and login status?